Patents-Review.com
ClassID:

96550 ⎘

C07J41/0061 - CPC Classification

Classification description:

Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group

Recent Application in this class:
#1
20260116910
2026-04-30

POLYCYCLIC COMPOUNDS AND METHODS THEREOF

 #2
20250376488
2025-12-11

FARNESOID X RECEPTOR MODULATORS

 #3
20250188113
2025-06-12

HIGH PURITY NON-ANIMAL DERIVED TUDCA

 #4
20240398834
2024-12-05

FARNESOID X RECEPTOR MODULATORS

 #5
20240294567
2024-09-05

FLUORINATED AND ALKYLATED BILE ACIDS

 #6
20240287125
2024-08-29

NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #7
20230340011
2023-10-26

STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS

 #8
20230331766
2023-10-19

METHOD FOR MASS-PRODUCING SODIUM TAURODEOXYCHOLATE

 #9
20230233581
2023-07-27

FARNESOID X RECEPTOR MODULATORS

 #10
20230146782
2023-05-11

DEOXYCHOLIC ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

 #11
20230135729
2023-05-04

COMPOUND WITH ANTI-SPORE ACTIVITY AND PHARMACEUTICAL COMPOSITION THEREOF

 #12
20230057232
2023-02-23

ISOTOPICALLY LABELED BILE ACID DERIVATIVES

 #13
20220402965
2022-12-22

STEROL ANALOGS AND USES THEREOF

 #14
20220380404
2022-12-01

TGR5 modulators and methods of use thereof

 #15
20220267367
2022-08-25

COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE

 #16
20220227804
2022-07-21

COMBINATION OF A POLYHYDROXYLATED BILE ACID AND A FARNESOID X RECEPTOR AGONIST

 #17
20220064207
2022-03-03

Neuroactive steroids and methods of use thereof

 #18
20220056070
2022-02-24

Methods of making cholic acid derivatives and starting materials therefor

 #19
20220054644
2022-02-24

NOVEL DRUG DELIVERY CONJUGATED MOIETY FOR ORAL ADMINISTRATION OF DRUG UNSUITABLE FOR ORAL ADMINISTRATION AND PREPARATION METHOD THEREOF

 #20
20220048943
2022-02-17

Oxysterols and methods of use thereof

 #21
20220024966
2022-01-27

Functionalized bile acids for therapeutic and material applications

 #22
20220002339
2022-01-06

Fluorinated and alkylated bile acids

 #23
20210299148
2021-09-30

Fluorinated bile acid derivatives

 #24
20210269475
2021-09-02

Farnesoid X receptor modulators

 #25
20210228599
2021-07-29

FARNESOID X RECEPTOR MODULATORS

 #26
20210179661
2021-06-17

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #27
20210122780
2021-04-29

COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PARKINSON'S DISEASE

 #28
20210122779
2021-04-29

TGR5 modulators and methods of use thereof

 #29
20210116467
2021-04-22

DIABETES-RELATED BIOMARKERS AND TREATMENT OF DIABETES-RELATED CONDITIONS

 #30
20200297739
2020-09-24

Farnesoid x receptor modulators

 #31
20200172566
2020-06-04

Functionalized bile acids for therapeutic and material applications

 #32
20200165290
2020-05-28

Isotopically labeled bile acid derivatives

 #33
20200165136
2020-05-28

Scroll composite having amphiphilic substance inside and method for preparation of the same

 #34
20200131223
2020-04-30

Compound for treating clostridium difficile

 #35
20200109163
2020-04-09

CARBONATED BEVERAGE AND METHOD FOR CARBONATION ENHANCEMENT

 #36
20200095274
2020-03-26

Methods for the purification of deoxycholic acid

 #37
20200078374
2020-03-12

POLYHYDROXYLATED BILE ACIDS FOR TREATMENT OF BILIARY DISORDERS

 #38
20190309012
2019-10-10

Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes

 #39
20190285656
2019-09-19

Diabetes-related biomarkers and treatment of diabetes-related conditions

 #40
20190284227
2019-09-19

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

 #41
20190284225
2019-09-19

TGR5 modulators and methods of use thereof

 #42
20190262362
2019-08-29

Amide derivatives of squalamine for the treatment of infections

 #43
20190211051
2019-07-11

Functionalized bile acids for therapeutic and material applications

 #44
20190209586
2019-07-11

Farnesoid X receptor modulators

 #45
20190135855
2019-05-09

Methods for the purification of deoxycholic acid

 #46
20190127414
2019-05-02

Neuroactive steroids and methods of use thereof

 #47
20190062367
2019-02-28

Methods for the preparation of obeticholic acid and derivatives thereof

 #48
20180306687
2018-10-25

Composition for clearing of biotissue and clarity method for biotissue using thereof

 #49
20180305395
2018-10-25

Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid

 #50
20180237470
2018-08-23

Neuroactive steroids and methods of use thereof

 #51
20180194797
2018-07-12

Oxysterols and methods of use thereof

 #52
20180148470
2018-05-31

CHOLIC ACID DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF

 #53
20180044373
2018-02-15

Fluorinated and alkylated bile acids

 #54
20180030084
2018-02-01

Deuterated bile acids

 #55
20170320906
2017-11-09

Compound for treating clostridium difficile

 #56
20170320905
2017-11-09

Methods for the purification of deoxycholic acid

 #57
20170305960
2017-10-26

NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF

 #58
20170266206
2017-09-21

Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport

 #59
20170196890
2017-07-13

TGR5 agonist complexes for treating diabetes and cancer

 #60
20170152283
2017-06-01

Inhibitors of the farnesoid x receptor and uses in medicine

 #61
20170101434
2017-04-13

Farnesoid X receptor modulators

 #62
20160355401
2016-12-08

Scroll composite having amphiphilic substance inside and method for preparation of the same

 #63
20160311851
2016-10-27

Methods for the synthesis of ceragenins

 #64
20160229886
2016-08-11

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

 #65
20160184325
2016-06-30

Polyhydroxylated bile acids for treatment of biliary disorders

 #66
20160168189
2016-06-16

Deuterated bile acids

 #67
20160159851
2016-06-09

Inhibitors of the farnesoid X receptor and uses in medicine

 #68
20160145296
2016-05-26

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

 #69
20160145295
2016-05-26

Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof

 #70
20160130297
2016-05-12

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

 #71
20160120880
2016-05-05

Bile acid-basic amino acid conjugates and uses thereof

 #72
20160116840
2016-04-28

Compound, active light sensitive or radiation sensitive resin composition, resist film using same, resist-coated mask blank, photomask, pattern forming method, method for manufacturing electronic device, and electronic device

 #73
20160096864
2016-04-07

Cationic steroidal antimicrobial prodrug compositions and uses thereof

 #74
20160060290
2016-03-03

Amphiphilic compounds

 #75
20160009753
2016-01-14

Reducing risk of contracting clostridium-difficile associated disease

 #76
20150141679
2015-05-21

Methods for the purification of deoxycholic acid

 #77
20150017093
2015-01-15

RADIOLABELED BILE ACIDS AND BILE ACID DERIVATIVES

 #78
20150011739
2015-01-08

Tandem facial amphiphiles

 #79
20140371190
2014-12-18

Farnesoid X receptor modulators

 #80
20140343571
2014-11-20

Robotic guidance of ultrasound probe in endoscopic surgery

 #81
20140271673
2014-09-18

Use of LXR antagonists for treatment of side effects of elevated glucocorticoid levels

 #82
20140162966
2014-06-12

NANOPARTICLES FOR DELIVERY OF LIGANDS

 #83
20140094443
2014-04-03

TGR5 modulators and methods of use thereof

 #84
20140088060
2014-03-27

METHOD OF TREATING DISORDER RELATED TO HIGH CHOLESTERAL CONCENTRATION

 #85
20140045808
2014-02-13

Reducing risk of contracting associated disease

 #86
20130266656
2013-10-10

Amphiphilic compounds

 #87
20130261317
2013-10-03

METHODS FOR PREPARING SYNTHETIC BILE ACIDS AND COMPOSITIONS COMPRISING THE SAME

 #88
20130190280
2013-07-25

Anti-diabetic compounds

 #89
20130115251
2013-05-09

Tandem facial amphiphiles

 #90
20120277198
2012-11-01

Polyhydroxylated bile acids for treatment of biliary disorders

 #91
20120202979
2012-08-09

Polymer-carbohydrate-lipid conjugates

 #92
20120202890
2012-08-09

POLYMER-CARBOHYDRATE-LIPID CONJUGATES

 #93
20110295025
2011-12-01

PROCESS FOR THE PREPARATION OF CHOLYL-L-LYSINE

 #94
20110160174
2011-06-30

Method Of Treating Disorder Related To High Cholesterol Concentration

 #95
20110003782
2011-01-06

23-substituted bile acids as TGR5 modulators and methods of use thereof

 #96
20100324126
2010-12-23

SYN3 compositions and methods

 #97
20100093687
2010-04-15

Method Of Treating Disorder Related To High Cholesterol Concentration

 #98
20100069654
2010-03-18

PROCESS FOR THE PREPARATION OF TAUROURSODESOXYCHOLIC ACID

 #99
20090258847
2009-10-15

Cholanic Acid Amides

 #100
20080234221
2008-09-25

TRANSFECTION AGENTS

 #101
20070232576
2007-10-04

Sulfated molecular umbrellas as anti-HIV and anti-HSV agents

 #102
20070197484
2007-08-23

Method of treating disorder related to high cholesterol concentration

 #103
20070088003
2007-04-19

Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

 #104
20070066575
2007-03-22

Methods and compositions for mitigating pain

 #105
20050137191
2005-06-23

Nitrate esters and their use for mitigating cellular damage

 #106
20050085427
2005-04-21

Transfection agents